Abstract:Objective: To construct a kind of paclitaxel-loaded long-circulating nanoliposomes actively targeting lung tumor in order to improve the tissue distribution of paclitaxel in vivo, and to promote the safety and the anti-tumor efficacy of paclitaxel administration. Methods: The complex of arginine glycine-aspartic acid-e-amino hexanoic acid linker-palmitate (RGD-EACA-Pal) was synthesized by solid-phase synthesis method. The sterically stabilized liposome of paclitaxel (SSL-PTX) and the active lung cancer-targeting sterically stabilized liposome of paclitaxel (T-SSL-PTX) were prepared by thin film ultrasonication-dispersion method, respectively. The pharmacokinetics, tissue distribution and the anti-tumor effects of two different formulations of paclitaxel were evaluated after intravenous injection of taxol, SSL-PTX or T-SSL-PTX in tumor-bearing nude mice. The maximum tolerance doses (MTDs) of two different formulations of paclitaxel were determined in Kunming mice. Results: Transmission electron microscopy (TEM) image showed that both SSL-PTX and T-SSL-PTX shaped regularly round and dispersed uniformly, and these two particle sizes were (83.4±36.7) nm and (94.7±41.2) nm, respectively. The encapsulation efficiencies of both SSL-PTX and T-SSL-PTX were at or above 95%. In vivo, the circulation time of SSL-PTX or T-SSL-PTX was longer than taxol, and the pharmacokinetic parameters of SSL-PTX and T-SSL-PTX were similar. Tumor-targeting efficiency of T-SSL-PTX was better than that of SSL-PTX or taxol, as well as the tissue distribution of T-SSL-PTX in normal organs was at a relatively low level as compared with that of SSL-PTX or taxol, in contribution to RGD specifically targeting tumors. The MTDs of SSL-PTX and T-SSL-PTX were higher than that of taxol. Compared with SSL-PTX and taxol with the same dose of paclitaxel, the anti-tumor efficacy of T-SSL-PTX was improved significantly (P＜0.05); and the mice received T-SSL-PTX therapy with a longer interval or at a lower dose also achieved significant tumor growth retardation.Conclusion: The lung cancer-targeting long-circulating nanoliposomes of paclitaxel may increase the safety and anti-tumor efficacy of paclitaxel through improving its pharmacokinetics and tissue distribution in vivo. DOI:10.3781/j.issn.1000-7431.2011.03.004

Evaluation of the Efficacy and Safety of a New Formulation-Lipid Emulsion-Based PTX Injection: Pharmacokinetics, Tissue Distributions and Anticancer Effect on Human Gastric Cancer Cells in Vitro.

Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pancreatic Cancer

Development And Evaluation Of A Novel Tpgs-Mediated Paclitaxel-Loaded Plga-Mpeg Nanoparticle For The Treatment Of Ovarian Cancer

Tumor-targeting intravenous lipid emulsion of paclitaxel: Characteristics, stability, toxicity, and toxicokinetics

Preparation of thermosensitive liposomes containing paclitaxel and their anticancer effect

The Anti-Tumor Effects of Lung Cancer-Targeting Long-Circulating Paclitaxel-Containing Liposomes

Quantification of paclitaxel in rat plasma by LC-MS/MS and pharmacokinetics of paclitaxel thermosensi-tive liposomes in rats

Improved oral absorption and anti-lung cancer activity of paclitaxel-loaded mixed micelles

Biodistribution and biological evaluation of paclitaxel polymer micelles

ANovel Paclitaxel Microemulsion Containing a Reduced Amount of Cremophor EL : Pharmacokinetics , Biodistribution , and InVivo Antitumor Efficacy and Safety

Selective Tissue Distribution and Long Circulation Endowed by Paclitaxel Loaded PEGylated Poly(ε-Caprolactone-co-l-lactide) Micelles Leading to Improved Anti-Tumor Effects and Low Systematic Toxicity.

Improved Anti-Tumor Activity and Safety Profile of a Paclitaxel-Loaded Glycyrrhetinic Acid-Graft-hyaluronic Acid Conjugate As a Synergistically Targeted Drug Delivery System

The Anticancer Efficacy of Paclitaxel Liposomes Modified with Low-Toxicity Hydrophobic Cell-Penetrating Peptides in Breast Cancer: an in Vitro and in Vivo Evaluation

Enhanced Antiproliferative and Apoptosis Effect of Paclitaxel-Loaded Polymeric Micelles Against Non-Small Cell Lung Cancers

Histology and Antitumor Activity Study of PTX-loaded Micelle, a Fluorescent Drug Delivery System Prepared by PEG-TPP

Synthesis, Biological Evaluation and Low-Toxic Formulation Development of Glycosylated Paclitaxel Prodrugs

In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle

In vivo evaluation of novel chitosan graft polymeric micelles for delivery of paclitaxel.

Enhanced in vivo Stability and Antitumor Efficacy of PEGylated Liposomes of Paclitaxel Palmitate Prodrug

Liposomal paclitaxel induces fewer hematopoietic and cardiovascular complications than bioequivalent doses of Taxol

An Optimized Two-Vial Formulation Lipid Nanoemulsion of Paclitaxel for Targeted Delivery to Tumor.